Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?
Werte in diesem Artikel
Investors in Repligen Corporation RGEN need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $110 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.What do the Analysts Think?Clearly, options traders are pricing in a big move for Repligen shares, but what is the fundamental picture for the company? Currently, Repligen is a Zacks Rank #3 (Hold) in the Medical - Biomedical and Genetics industry that ranks in the Top 30% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased the earnings estimates for the current quarter, while five have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from 42 cents per share to 40 cents in that period.Given the way analysts feel about Repligen right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.Looking to Trade Options?Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.Click to see the trades now >>Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Repligen Corporation (RGEN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Repligen und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Repligen
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Repligen
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Repligen Corp.
Analysen zu Repligen Corp.
Datum | Rating | Analyst | |
---|---|---|---|
28.08.2019 | Repligen Outperform | First Analysis Securities | |
22.07.2019 | Repligen Buy | H.C. Wainwright & Co. | |
26.09.2018 | Repligen Neutral | H.C. Wainwright & Co. | |
02.10.2017 | Repligen Overweight | First Analysis Securities | |
29.10.2009 | Repligen neues Kursziel | Merriman Curhan Ford & Co |
Datum | Rating | Analyst | |
---|---|---|---|
28.08.2019 | Repligen Outperform | First Analysis Securities | |
22.07.2019 | Repligen Buy | H.C. Wainwright & Co. | |
02.10.2017 | Repligen Overweight | First Analysis Securities | |
29.10.2009 | Repligen neues Kursziel | Merriman Curhan Ford & Co | |
30.06.2009 | Repligen buy | Merriman Curhan Ford & Co |
Datum | Rating | Analyst | |
---|---|---|---|
26.09.2018 | Repligen Neutral | H.C. Wainwright & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Repligen Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen